Home
Productsindex
Gene
BioActive Proteinsindex
BioActive Biomarker Proteinslists
BioActive Human AR (L702H,T878A) Recombinant Protein,Fc Tag
SGRP00650
BioActive Human AR (L702H,T878A) Recombinant Protein,Fc Tag
Source:Full length Human AR overexpression, expressed in HEK293 cells.
SKU:SGRP00650-100UG
Product Name:BioActive Human AR (L702H,T878A) Recombinant Protein,Fc Tag
Product Description:Human AR with mutation L702H,T878A expressed in HEK293 cells with activity confimed by ELISA.
SKU:SGRP00650-100UG
Product Name:BioActive Human AR (L702H,T878A) Recombinant Protein,Fc Tag
Product Description:Human AR with mutation L702H,T878A expressed in HEK293 cells with activity confimed by ELISA.
PROPERTIES
Biological Activity:
Fully biologically active
Purity:
> 95% by SDS-PAGE & HPLC
Endotoxin Level:
< 1.0 EU per μg protein as determined by the LAL method
Expression System:
HEK293 Cells
Format:
Recombinant
Species:
Human
Applications:
Sandwich ELISA Functional Studies Mass Spectrometry SDS-PAGE HPLC
Form:
Lyophilized from sterile PBS, pH 7.33
Concentration:
N/A
Stability and Storage:
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution:
Reconstitute with Phosphate Buffered Saline.
Related Categories
BioActive Biomarker Proteins
Background

Gene Accession

P29276

Gene Alias

Protein names Recommended name Adenosine receptor A2a Gene names Name ADORA2A Synonyms ADORA4

Background

L702H mutation was reported in abiraterone- and enzalutamide-resistant patients receiving glucocorticoid treatment. This agrees with Lallous et al. functional studies, showing that L702H is the only single mutant activated by hydrocortisone. The T878A, H875Y and the L702H mutations have been observed in CRPC patients progressing during abiraterone treatment and associated with either the increased progesterone levels obtained after CYP17 inhibition or with the co-administration of exogenous glucocorticoids given to compensate for significantly reduced cortisol levels. The activating AR point mutations T877A, L702H and H875Y have been detected in cfDNA from patients with CRPC and shown to be associated with resistance to abiraterone and enzalutamide.

RECOMMENDED PRODUCTS
BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
ABL1

SGRP00624

BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
ABL1

SGRP00628

BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
AKT1

SGRP00630

BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
AKT1

SGRP00631

BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
ALK

SGRP00637

BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
View Price and Availability
0.132487s